Cover Image
市場調查報告書

俄羅斯的生物醫藥品及生物醫療的市場

The Russian Biopharmaceuticals and Biomedicine Market

出版商 Frost & Sullivan 商品編碼 321259
出版日期 內容資訊 英文 89 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
俄羅斯的生物醫藥品及生物醫療的市場 The Russian Biopharmaceuticals and Biomedicine Market
出版日期: 2014年12月16日 內容資訊: 英文 89 Pages
簡介

本報告提供俄羅斯的生物醫藥品及生物醫療的市場相關調查、俄羅斯的經濟及醫療部門概要、政府的支援機制、國家及民間的投資趨勢、生物醫藥品及生物醫療的主要各部門的發展趨勢、市場成長預測等彙整資料。

摘要整理

  • 關注的企業
  • 調查範圍及目的

俄羅斯經濟的概述

  • 俄羅斯經濟概要
  • 醫療市場概要

生物醫藥品市場概要

  • 生物醫藥品市場概要
  • 推動市場要素
  • 推進因素的說明
  • 阻礙市場要素
  • 阻礙要素的說明
  • 俄羅斯的生物醫藥品市場:收益預測
  • 法律制度
  • 生物科技開發的俄羅斯的複雜計劃
  • 主要的政府支援機制:概要
  • 主要的政府支援機制:生物科技部門
  • 主要的政府支援機制:技術平台
  • 主要的政府支援機制:ZHNVLP清單與進口替代品
  • 對生化科技的投資:國家的開發相關機關
  • 對生化科技的投資:創業投資
  • 生物醫藥品市場:各部門的收益明細

生物醫藥品:細胞激素、PKI及凝血劑、荷爾蒙劑、單株抗體部門

  • 細胞激素
  • PKI及凝血劑
  • 荷爾蒙劑
  • 單株抗體

生物醫藥品:疫苗部門

  • 疫苗

生物醫藥品:抗生素及噬菌體部門

  • 抗生素及噬菌體

生物醫療市場:概要

  • 推動市場要素
  • 推進因素的說明
  • 阻礙市場要素
  • 阻礙要素的說明

生物醫療:細胞技術、基因治療、再生醫療部門

  • 細胞技術、基因治療、再生醫療

生物醫療:奈米醫療、標的藥物輸送部門

  • 奈米醫療、標的藥物輸送

生物醫療:生物適合性、生物分解性醫療材料部門

  • 生物適合性、生物分解性醫療材料
  • 生物適合性、生物分解性醫療材料:技術平台「Medicine of the Future」計劃

生物醫療:診斷系統生物晶片、生物感應器部門

  • 診斷系統生物晶片、生物感應器

生物醫療:系統生物學、後基因體技術、生物資訊學部門

  • 系統生物學、後基因體技術、生物資訊學

彙整

  • 3大預測
  • 法律上的免責聲明

附錄

關於Frost&Sullivan

目錄
Product Code: 9AB9-00-15-00-00

From Import Substitution to Innovation

This study covers the Russian biopharmaceutical and biomedicine markets. Key segments for the biopharmaceutical market include cytokines, monoclonal antibodies, vaccines, and antibiotics. The biomedicine market includes regenerative medicine, nanomedicine, biocompatible medical materials, diagnostics, post-genomic technologies, and bioinformatics. This research shows the latest developments in Russian biotechnology, defines key segments and emerging leaders, and outlines government policies and support mechanisms. The base year for the study is 2013 with a forecast period of 2014 to 2018.

Table of Contents

Executive Summary

  • 1. Executive Summary (continued)
  • 2. Executive Summary
  • 3. Key Companies to Watch in 2015
  • 4. Research Scope and Objective

Russian Economy Snapshot

  • 1. Russian Economy Overview
  • 2. Healthcare Market Overview

Biopharmaceuticals Market Overview

  • 1. Biopharmaceuticals Market Overview
  • 2. Biopharmaceuticals Market Overview (continued)
  • 3. Market Drivers
  • 4. Drivers-Explained
  • 5. Market Restraints
  • 6. Restraints-Explained
  • 7. Russian Biopharmaceuticals Market-Revenue Forecast
  • 8. Regulatory Environment
  • 9. Complex Program for Development of Biotechnology in the Russian Federation Until 2020
  • 10. Complex Program for Development of Biotechnology in the Russian Federation Until 2020 (continued)
  • 11. Key Government Support Mechanisms-Overview
  • 12. Key Government Support Mechanisms-Biotech Clusters
  • 13. Key Government Support Mechanisms-Biotech Clusters (continued)
  • 14. Key Government Support Mechanisms-Technology Platforms
  • 15. Key Government Support Mechanisms-ZHNVLP List and Import Substitution
  • 16. Biotechnology Investment-State Development Institutions
  • 17. Biotechnology Investment-Venture Capital
  • 18. Biopharmaceuticals Market-Percent Revenue Breakdown by Segment

Biopharmaceuticals-Cytokines, PKI and Coagulants, Hormones, and Monoclonal Antibodies Segments

  • 1. Biopharmaceuticals Segment Overview-Cytokines
  • 2. Biopharmaceuticals Segment Overview-PKI and Coagulants
  • 3. Biopharmaceuticals Segment Overview-Hormones
  • 4. Biopharmaceuticals Segment Overview-Monoclonal Antibodies

Biopharmaceuticals-Vaccines Segment

  • 1. Vaccines Segment
  • 2. Vaccines Segment (continued)
  • 3. Vaccines Segment (continued)
  • 4. Vaccines Segment (continued)
  • 5. Vaccines Segment (continued)

Biopharmaceuticals-Antibiotics and Bacteriophages Segment

  • 1. Antibiotics and Bacteriophages
  • 2. Antibiotics and Bacteriophages (continued)
  • 3. Antibiotics and Bacteriophages (continued)

Biomedicine Market Overview

  • 1. Biomedicine Market Overview
  • 2. Biomedicine Market Overview (continued)
  • 3. Market Drivers
  • 4. Drivers-Explained
  • 5. Market Restraints
  • 6. Restraints-Explained

Biomedicine-Cell Technologies, Gene Therapy, and Regenerative Medicine Segment

  • 1. Cell Technologies, Gene Therapy, and Regenerative Medicine
  • 2. Cell Technologies, Gene Therapy, and Regenerative Medicine (continued)
  • 3. Cell Technologies, Gene Therapy, and Regenerative Medicine (continued)

Biomedicine-Nanomedicine and Targeted Drug Delivery Segment

  • 1. Nanomedicine and Targeted Drug Delivery
  • 2. Nanomedicine and Targeted Drug Delivery (continued)

Biomedicine-Biocompatible and Biodegradable Medical Materials Segment

  • 1. Biocompatible and Biodegradable Medical Materials
  • 2. Biocompatible and Biodegradable Medical Materials (continued)
  • 3. Biocompatible and Biodegradable Medical Materials-Projects of TP "Medicine of the Future"
  • 4. Biocompatible and Biodegradable Medical Materials-Projects of TP "Medicine of the Future" (continued)
  • 5. Biocompatible and Biodegradable Medical Materials-Projects of TP "Medicine of the Future" (continued)

Biomedicine-Diagnostic Systems, Biochips and Biosensors Segment

  • 1. Diagnostics Systems, Biochips, and Biosensors
  • 2. Diagnostics Systems, Biochips, and Biosensors (continued)
  • 3. Diagnostics Systems, Biochips, and Biosensors (continued)

Biomedicine-Systems Biology, Post-genomics Technologies, and Bioinformatics Segments

  • 1. Systems Biology, Post-genomics Technologies, Bioinformatics
  • 2. Systems Biology, Post-genomics Technologies, Bioinformatics (continued)
  • 3. Systems Biology, Post-genomics Technologies, Bioinformatics (continued)
  • 4. Systems Biology, Post-genomics Technologies, Bioinformatics (continued)

The Last Word

  • 1. Three Big Predictions
  • 2. Legal Disclaimer

Appendix

  • 1. Import Substitution of Biopharmaceuticals From the ZHNVLP List
  • 2. Import Substitution of Biopharmaceuticals From the ZHNVLP List (continued)
  • 3. Import Substitution of Biopharmaceuticals From the ZHNVLP List (continued)
  • 4. List of Acronyms

The Frost & Sullivan Story

  • 1. The Frost & Sullivan Story
  • 2. Value Proposition
  • 3. Global Perspective
  • 4. Industry Convergence
  • 5. 360° Research Perspective
  • 6. Implementation Excellence
  • 7. Our Blue Ocean Strategy
Back to Top